Elanco Animal Health, Inc. (ELAN)
22.52
-0.17
(-0.75%)
USD |
NYSE |
Oct 23, 16:00
22.52
0.00 (0.00%)
After-Hours: 20:00
Elanco Animal Health Enterprise Value : 14.64B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 14.64B |
| October 22, 2026 | 14.72B |
| October 21, 2026 | 14.65B |
| October 20, 2026 | 14.73B |
| October 19, 2026 | 15.12B |
| October 16, 2026 | 15.15B |
| October 15, 2026 | 15.15B |
| October 14, 2026 | 14.65B |
| October 13, 2026 | 14.58B |
| October 12, 2026 | 14.66B |
| October 09, 2026 | 14.84B |
| October 08, 2026 | 14.65B |
| October 07, 2026 | 14.56B |
| October 06, 2026 | 14.62B |
| October 05, 2026 | 14.63B |
| October 02, 2026 | 14.45B |
| October 01, 2026 | 14.26B |
| September 30, 2026 | 14.57B |
| September 29, 2026 | 14.68B |
| September 28, 2026 | 14.60B |
| September 25, 2026 | 14.53B |
| September 24, 2026 | 14.55B |
| September 23, 2026 | 14.66B |
| September 22, 2026 | 14.84B |
| September 21, 2026 | 14.59B |
| Date | Value |
|---|---|
| September 18, 2026 | 14.59B |
| September 17, 2026 | 14.75B |
| September 16, 2026 | 14.81B |
| September 15, 2026 | 14.88B |
| September 14, 2026 | 14.95B |
| September 11, 2026 | 14.96B |
| September 10, 2026 | 14.81B |
| September 09, 2026 | 15.15B |
| September 08, 2026 | 15.36B |
| September 04, 2026 | 15.63B |
| September 03, 2026 | 15.59B |
| September 02, 2026 | 15.72B |
| September 01, 2026 | 15.33B |
| August 31, 2026 | 15.34B |
| August 28, 2026 | 15.43B |
| August 27, 2026 | 15.62B |
| August 26, 2026 | 15.92B |
| August 25, 2026 | 15.92B |
| August 24, 2026 | 15.59B |
| August 21, 2026 | 15.36B |
| August 20, 2026 | 15.16B |
| August 19, 2026 | 15.63B |
| August 18, 2026 | 15.20B |
| August 17, 2026 | 15.18B |
| August 14, 2026 | 15.21B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Eli Lilly & Co. | 1.245T |
| Zoetis, Inc. | 41.12B |
| ANI Pharmaceuticals, Inc. | 1.903B |
| Corcept Therapeutics, Inc. | 8.967B |
| Veru, Inc. | 15.08M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 54.00M |
| Revenue (Quarterly) | 1.368B |
| Total Expenses (Quarterly) | 1.314B |
| EPS Diluted (Quarterly) | 0.1067 |
| Gross Profit Margin (Quarterly) | 48.17% |
| Profit Margin (Quarterly) | 3.95% |
| Earnings Yield | -1.80% |
| Operating Earnings Yield | 2.95% |
| Normalized Earnings Yield | -0.3832 |